suramin has been researched along with dehydroepiandrosterone sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, MR; Danesi, R; Ewing, MW; Jamis-Dow, CA; La Rocca, RV; Linehan, WM; Myers, CE | 1 |
| Hsieh, HL; Lin, CM; Liu, PS | 1 |
2 other study(ies) available for suramin and dehydroepiandrosterone sulfate
| Article | Year |
|---|---|
Effect of suramin on human prostate cancer cells in vitro.
Topics: Adenocarcinoma; Androstenedione; Antineoplastic Agents; Cell Line; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; In Vitro Techniques; Male; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured | 1991 |
Dehydroepiandrosterone sulfate (DHEAS) suppresses P2X purinoceptor-coupled responses in PC12 cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Cytosol; Dehydroepiandrosterone Sulfate; Dopamine Antagonists; Drug Synergism; Osmolar Concentration; PC12 Cells; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X; Sodium; Suramin; Uridine Triphosphate | 2001 |